These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2375247)

  • 21. CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.
    Molchan SE; Hill JL; Martinez RA; Lawlor BA; Mellow AM; Rubinow DR; Bissette G; Nemeroff CB; Sunderland T
    Psychoneuroendocrinology; 1993; 18(7):509-19. PubMed ID: 7903467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between psychological distress, coping styles, and HPA axis reactivity in healthy adults.
    Hori H; Ozeki Y; Teraishi T; Matsuo J; Kawamoto Y; Kinoshita Y; Suto S; Terada S; Higuchi T; Kunugi H
    J Psychiatr Res; 2010 Oct; 44(14):865-73. PubMed ID: 20334880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G; Mathé AA; Czernik A; Thiele J; Bohner J; Eap CB; Agren H; Baumann P
    Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels.
    Dimopoulou I; Tsagarakis S; Kouyialis AT; Roussou P; Assithianakis G; Christoforaki M; Ilias I; Sakas DE; Thalassinos N; Roussos C
    Crit Care Med; 2004 Feb; 32(2):404-8. PubMed ID: 14758155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B; Sherman B; Schlechte J; Stone R
    Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the hypothalamic-pituitary-adrenal axis in dementia disorders.
    Gottfries CG; Balldin J; Blennow K; Bråne G; Karlsson I; Regland B; Wallin A
    Ann N Y Acad Sci; 1994 Nov; 746():336-43; discussion 343-4. PubMed ID: 7825888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease.
    Näsman B; Olsson T; Fagerlund M; Eriksson S; Viitanen M; Carlström K
    Biol Psychiatry; 1996 Mar; 39(5):311-8. PubMed ID: 8704061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid corticotropin-releasing factor (CRF) and vasopressin concentrations predict pituitary response in the CRF stimulation test: a multiple regression analysis.
    Newport DJ; Heim C; Owens MJ; Ritchie JC; Ramsey CH; Bonsall R; Miller AH; Nemeroff CB
    Neuropsychopharmacology; 2003 Mar; 28(3):569-76. PubMed ID: 12629539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Function of the hypothalamo-hypophyseal-adrenal axis to corticotropin-releasing hormone test in premature infants with bronchopulmonary dysplasia].
    Merz U; Pfäffle R; Peschgens T; Hörnchen H
    Z Geburtshilfe Neonatol; 1997; 201(6):253-7. PubMed ID: 9491545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenocortical response to ovine corticotropin-releasing hormone in young men: cortisol measurement in matched samples of saliva and plasma.
    Kumar AM; Solano MP; Fernandez JB; Kumar M
    Horm Res; 2005; 64(2):55-60. PubMed ID: 16103684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of hypothalamic-pituitary-adrenal axis and sympathetic nervous system activity in pregnant sows through the measurement of glucocorticoids and catecholamines in urine.
    Hay M; Meunier-Salaün MC; Brulaud F; Monnier M; Mormède P
    J Anim Sci; 2000 Feb; 78(2):420-8. PubMed ID: 10709934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis.
    Grasser A; Möller A; Backmund H; Yassouridis A; Holsboer F
    Exp Clin Endocrinol Diabetes; 1996; 104(1):31-7. PubMed ID: 8750568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovine corticotropin-releasing hormone stimulation test in patients with chronic renal failure: pharmacokinetic properties, and plasma adrenocorticotropic hormone and serum cortisol responses.
    Siamopoulos KC; Eleftheriades EG; Pappas M; Sferopoulos G; Tsolas O
    Horm Res; 1988; 30(1):17-21. PubMed ID: 2851525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine changes in Alzheimer's disease.
    Davidson M; Bastiaens L; Davis BM; Shah MB; Davis KL
    Neurol Clin; 1988 Feb; 6(1):149-57. PubMed ID: 2898094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormalities in the hypothalamic-pituitary-adrenocortical axis in patients with chronic renal failure.
    Luger A; Lang I; Kovarik J; Stummvoll HK; Templ H
    Am J Kidney Dis; 1987 Jan; 9(1):51-4. PubMed ID: 3028134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder.
    Watson S; Gallagher P; Ritchie JC; Ferrier IN; Young AH
    Br J Psychiatry; 2004 Jun; 184():496-502. PubMed ID: 15172943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.